← Leaderboards
Bachir Taouli
Icahn School Of Medicine At Mount Sinai
$9,208,757
Attributed
$14,184,331
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,184,331 · 5
By mechanism
R01$8,196,640 · 3
U01$5,987,691 · 2
Top collaborators
- Mustafa R. Bashir5 shared
- Scott B. Reeder5 shared
- Claude B Sirlin5 shared
- Augusto Villanueva3 shared
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Augusto Villanueva$1,669,125
- David Peter Cormode$8,115,709
- Mustafa R. Bashir$1,102,150
Others in their field
Top investigators on “Liver”
- David Heimbrook · Leidos Biomedical Research, Inc.$183,557,534
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Richard Douglas Moore · Johns Hopkins University$59,048,354
- Paul M. Ridker · Brigham And Women'S Hospital$55,416,022
- Michael S. Saag · University Of Alabama At Birmingham$50,288,385
- Mark A Kay · Stanford University$49,905,067
Research focus
LiverValidationCirrhosisUnited StatesPrimary Carcinoma Of The Liver CellsImageDetectionBaseTrainingPerformanceHigh RiskMagnetic Resonance ImagingAmericanProspective StudiesMorbidity - Disease RateDiagnosticEarly DiagnosisCostEvaluationFibrosisLiver DiseasesReproducibilityPatient PopulationSampling
Grant awards (23)
Liquid biopsy and radiomics for liver cancer surveillance$1,984,454
U01 · FY2025 · CA · contact PI
Abbreviated MRI for HCC screening in cirrhotic patients$799,358
R01 · FY2024 · CA · contact PI
Liquid biopsy and radiomics for liver cancer surveillance$633,414
U01 · FY2024 · CA
Abbreviated MRI for HCC screening in cirrhotic patients$883,658
R01 · FY2023 · CA · contact PI
Liquid biopsy and radiomics for liver cancer surveillance$720,382
U01 · FY2023 · CA
Abbreviated MRI for HCC screening in cirrhotic patients$894,475
R01 · FY2022 · CA · contact PI
Abbreviated MRI for HCC screening in cirrhotic patients$883,588
R01 · FY2021 · CA · contact PI
Prediction of portal pressure with liver and spleen MR Elastography and 4D flow phase-contrast MRI$470,763
R01 · FY2021 · DK · contact PI
Abbreviated MRI for HCC screening in cirrhotic patients$947,520
R01 · FY2020 · CA · contact PI
Prediction of portal pressure with liver and spleen MR Elastography and 4D flow phase-contrast MRI$525,202
R01 · FY2020 · DK · contact PI
Prediction of portal pressure with liver and spleen MR Elastography and 4D flow phase-contrast MRI$526,905
R01 · FY2019 · DK · contact PI
Prediction of portal pressure with liver and spleen MR Elastography and 4D flow phase-contrast MRI$513,907
R01 · FY2018 · DK · contact PI
Evaluation of HCC Response to Systemic Therapy with Quantitative MRI$485,638
U01 · FY2017 · CA · contact PI
Evaluation of HCC Response to Systemic Therapy with Quantitative MRI$514,057
U01 · FY2016 · CA · contact PI
Evaluation of HCC Response to Systemic Therapy with Quantitative MRI$530,147
U01 · FY2015 · CA · contact PI
Evaluation of HCC Response to Systemic Therapy with Quantitative MRI$493,413
U01 · FY2014 · CA · contact PI
Detection of Liver Fibrosis Using IVIM Diffusion and DCE MRI in HCV$335,688
R01 · FY2014 · DK · contact PI
Evaluation of HCC Response to Systemic Therapy with Quantitative MRI$81,563
U01 · FY2014 · CA · contact PI
Evaluation of HCC Response to Systemic Therapy with Quantitative MRI$544,623
U01 · FY2013 · CA · contact PI
Detection of Liver Fibrosis Using IVIM Diffusion and DCE MRI in HCV$324,650
R01 · FY2013 · DK · contact PI
Detection of Liver Fibrosis Using IVIM Diffusion and DCE MRI in HCV$337,178
R01 · FY2012 · DK · contact PI
Detection of Liver Fibrosis Using IVIM Diffusion and DCE MRI in HCV$337,950
R01 · FY2011 · DK · contact PI
Detection of Liver Fibrosis Using IVIM Diffusion and DCE MRI in HCV$415,798
R01 · FY2010 · DK · contact PI